HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dynamic, adaptive changes in MAO-A binding after alterations in substrate availability: an in vivo [(11)C]-harmine positron emission tomography study.

Abstract
Monoamine oxidase A (MAO-A) is an important target in the pathophysiology and therapeutics of major depressive disorder, aggression, and neurodegenerative conditions. We measured the effect of changes in MAO-A substrate on MAO-A binding in regions implicated in affective and neurodegenerative disease with [(11)C]-harmine positron emission tomography in healthy volunteers. Monoamine oxidase A V(T), an index of MAO-A density, was decreased (mean: 14%±9%) following tryptophan depletion in prefrontal cortex (P<0.031), and elevated (mean: 17%±11%) in striatum following carbidopa-levodopa administration (P<0.007). These findings suggest an adaptive role for MAO-A in maintaining monoamine neurotransmitter homeostasis by rapidly compensating fluctuating monoamine levels.
AuthorsJulia Sacher, Eugenii A Rabiner, Michael Clark, Pablo Rusjan, Alexandra Soliman, Rada Boskovic, Stephen J Kish, Alan A Wilson, Sylvain Houle, Jeffrey H Meyer
JournalJournal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism (J Cereb Blood Flow Metab) Vol. 32 Issue 3 Pg. 443-6 (Mar 2012) ISSN: 1559-7016 [Electronic] United States
PMID22186668 (Publication Type: Journal Article, Randomized Controlled Trial, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Carbon Radioisotopes
  • Dopamine Agonists
  • Drug Combinations
  • carbidopa, levodopa drug combination
  • Serotonin
  • Levodopa
  • Harmine
  • Tryptophan
  • Monoamine Oxidase
  • Carbidopa
  • Dopamine
Topics
  • Carbidopa (administration & dosage, blood, pharmacology)
  • Carbon Radioisotopes
  • Corpus Striatum (enzymology, metabolism)
  • Dopamine (metabolism)
  • Dopamine Agonists (administration & dosage, blood, pharmacology)
  • Drug Combinations
  • Harmine (metabolism)
  • Humans
  • Levodopa (administration & dosage, blood, pharmacology)
  • Monoamine Oxidase (metabolism)
  • Parkinson Disease (enzymology)
  • Positron-Emission Tomography
  • Prefrontal Cortex (enzymology, metabolism)
  • Protein Binding
  • Serotonin (metabolism)
  • Substrate Specificity
  • Time Factors
  • Tryptophan (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: